Stephen Mills
Affiliations: | Pharmacology | University of Oxford, Oxford, United Kingdom |
Google:
"Stephen Mills"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Su X, Dohle W, Mills SJ, et al. (2020) Inositol Adenophostin: Convergent Synthesis of a Potent Agonist of d--Inositol 1,4,5-Trisphosphate Receptors. Acs Omega. 5: 28793-28811 |
| Mills SJ, Rossi AM, Konieczny V, et al. (2020) D-chiro-Inositol Ribophostin: a Highly Potent Agonist at D-myo-Inositol 1,4,5-Trisphosphate Receptors: Synthesis and Biological Activities. Journal of Medicinal Chemistry |
| Dohle W, Su X, Mills SJ, et al. (2019) A synthetic cyclitol-nucleoside conjugate polyphosphate is a highly potent second messenger mimic. Chemical Science. 10: 5382-5390 |
| Mills SJ, Silvander C, Cozier GE, et al. (2016) Crystal Structures of Type-II Inositol Polyphosphate 5-Phosphatase INPP5B with Synthetic Inositol Polyphosphate Surrogates Reveal New Mechanistic Insights for the Inositol 5-Phosphatase Family. Biochemistry |
| Thomas MP, Mills SJ, Potter BV. (2015) The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). Angewandte Chemie (International Ed. in English) |
| Swarbrick JM, Riley AM, Mills SJ, et al. (2015) Designer small molecules to target calcium signalling Biochemical Society Transactions. 43: 417-425 |
| Mills SJ, Luyten T, Erneux C, et al. (2012) Multivalent benzene polyphosphate derivatives are non-Ca(2+)-mobilizing Ins(1,4,5)P3 receptor antagonists. Messenger (Los Angeles, Calif. : Print). 1: 167-181 |
| Grint T, Riley AM, Mills SJ, et al. (2012) Fibrinogen - a possible extracellular target for inositol phosphates. Messenger (Los Angeles, Calif. : Print). 1: 160-166 |
| Mills SJ, Persson C, Cozier G, et al. (2012) A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery. Acs Chemical Biology. 7: 822-8 |
| MILLS SJ, RILEY AM, MURPHY CT, et al. (2010) ChemInform Abstract: myo-Inositol 1,4,6-Trisphosphorothioate and myo-Inositol 1,3,4- Trisphosphorothioate: New Synthetic Ca2+-Mobilizing Partial Agonists at the Inositol 1,4,5-Trisphosphate Receptor. Cheminform. 26: no-no |